Crinetics Pharmaceuticals, Inc. Deferred Tax Assets, Equity Method Investments
Crinetics Pharmaceuticals, Inc. (CRNX) had Deferred Tax Assets, Equity Method Investments of $3.42 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsEquityMethodInvestments · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Equity Method Investments $3.42M.
- 2024-12-31: Deferred Tax Assets, Equity Method Investments $3.54M.
- 2023-12-31: Deferred Tax Assets, Equity Method Investments $3.23M.
- 2022-12-31: Deferred Tax Assets, Equity Method Investments $0.00.
| Period end | Deferred Tax Assets, Equity Method Investments |
|---|---|
| 2025-12-31 | $3.42M 10-K · filed 2026-02-26 |
| 2024-12-31 | $3.54M 10-K · filed 2026-02-26 |
| 2023-12-31 | $3.23M 10-K · filed 2025-02-27 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-28 |